Akero Therapeutics Inc. is a cardio-metabolic non-alcoholic steatohepatitis (NASH) company. The Company is focused on developing medicines designed to restore metabolic balance and improve the overall health of patients with NASH. Its lead product ca... Read more
MarketWatch
Yahoo
CNBC
Yahoo
Access detailed stock analysis from LSEG including analyst price target estimates.